BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2591999)

  • 21. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
    Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
    Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-Hodgkin's lymphomas associated with the acquired immunodeficiency syndrome. A multicenter clinical study of 77 cases].
    Rubio R; Pulido F; Pintado V; Díaz-Mediavilla J; Flores E; Serrano M; Alberdi JC; López-Gay D; Verdejo J; Barros C
    Med Clin (Barc); 1995 Apr; 104(13):481-6. PubMed ID: 7746011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
    Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
    Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognosis in Hodgkin's disease: verification of a new predictive equation].
    Bettini R; Quadrelli G; Quadrelli CM; Biganzoli L; Venco A
    Recenti Prog Med; 1990 Sep; 81(9):579-80. PubMed ID: 2263753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute myeloid leukaemia in the course of Hodgkin's disease (author's transl)].
    Cavalli F; Gerber A; Mosimann W; Sonntag RW; Tschopp L
    Dtsch Med Wochenschr; 1977 Jul; 102(28):1019-24. PubMed ID: 268267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hodgkin's disease in the bone marrow.
    Weiss RB; Brunning RD; Kennedy BJ
    Cancer; 1975 Dec; 36(6):2077-83. PubMed ID: 1203865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow involvement at onset of Hodgkin's disease.
    Cimino G; Anselmo AP; De Luca AM; Fidani P; Mauro F; Marzullo A; Maurizi Enrici R; Papa G
    Tumori; 1983 Feb; 69(1):47-51. PubMed ID: 6836748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and clinical importance of bone marrow eosinophilia in Hodgkin's disease (BNLI Report No 29). British National Lymphoma Investigation.
    Macintyre EA; Vaughan Hudson B; Vaughan Hudson G; Jelliffe AM; Linch DC
    J Clin Pathol; 1987 Mar; 40(3):245-6. PubMed ID: 3558856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical factors predictive of bone marrow involvement in Hodgkin's disease.
    Spector N; Nucci M; Oliveira De Morais JC; Maiolino A; Portugal RD; Costa MA; Pulcheri W
    Leuk Lymphoma; 1997 Jun; 26(1-2):171-6. PubMed ID: 9250802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic factors in idiopathic myeloid splenomegaly].
    Vorhauer-Atlan W; Briere J; Jacquillat C; Najean Y; Laval-Jeantet M; Chelloul N
    Ann Anat Pathol (Paris); 1975; 20(3):259-76. PubMed ID: 1211674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splenectomy in Hodgkin's Disease for splenomegaly, cytopenias and intolerance to myelosuppressive chemotherapy.
    Lowenbraun S; Ramsey HE; Serpick AA
    Am J Med; 1971 Jan; 50(1):49-55. PubMed ID: 5539576
    [No Abstract]   [Full Text] [Related]  

  • 33. Prompt reversal of myelofibrosis and hypochromia in Hodgkin's disease.
    Akinyanju O; Akinsete I
    Niger Med J; 1979 Mar; 9(3):387-8. PubMed ID: 543286
    [No Abstract]   [Full Text] [Related]  

  • 34. Myelofibrosis in children: experience at a single tertiary care center in India.
    Arya LS; Thavraj V; Chandra D; Kulkarni KP; Kumar R; Dawar R
    Pediatr Hematol Oncol; 2010 Aug; 27(5):355-62. PubMed ID: 20670165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hodgkin's disease disclosed by myelofibrosis of primary appearance. Apropos of 2 cases].
    Fenaux P; Jouet JP; Delerive C; Simon M; Pollet JP; Savinel P; Fabri MC; Ciesla I; Gosselin B; Bauters F
    Rev Med Interne; 1988; 9(2):149-52. PubMed ID: 3420330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approach to tuberculosis of the bone marrow.
    Mehta J; Singhal S; Mehta BC
    J Assoc Physicians India; 1992 Sep; 40(9):639-40. PubMed ID: 1308038
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of myelofibrosis in malignant leukoerythroblastosis.
    Rubins JM
    Cancer; 1983 Jan; 51(2):308-11. PubMed ID: 6821819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hodgkin's disease: intramedullary phagocytosis with pancytopenia.
    Korman LY; Smith JR; Landaw SA; Davey FR
    Ann Intern Med; 1979 Jul; 91(1):60-1. PubMed ID: 464459
    [No Abstract]   [Full Text] [Related]  

  • 39. Hodgkin's disease: an unusual termination.
    Mavor WO; Adams P
    Postgrad Med J; 1967 Jul; 43(501):490-1. PubMed ID: 6041642
    [No Abstract]   [Full Text] [Related]  

  • 40. Hodgkin's disease with bone marrow involvement.
    Gupta R; Parikh PM; Advani SH; Charak BS; Saikia T; Dinshaw KA; Gonsalves MA; Gopal R; Nair CN; Nadkarni KS
    Indian J Cancer; 1989 Jun; 26(2):58-66. PubMed ID: 2591999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.